Freeport McMoran: With Copper Prices Rising, It's Still a Buy [View article]
IMHO it is quite plausible that due to the high energy cost (and inflation) and bear market for stocks that there is also a pullback for the FCX s.p. The candlestick shows that the pullback is NOT YET over. Most likely there will be a pullback well below the 200-DMA. Wait and see....
Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO [View article]
It is a pity that not also is commented on the 3 encouraging clinical trials of Genvec for : 1. pancreatic tumor- Phase 3 2. esophageal tumor- Phase 2 3. Head and neck tumor: Phase 1
Genentech is a MegaCap company and GNVC is a SmallCap company. Hence, the effect on GNVC s.p. is most likely more significant.
Sort by:
Latest | Highest ratedFreeport McMoran: With Copper Prices Rising, It's Still a Buy [View article]
The candlestick shows that the pullback is NOT YET over. Most likely there will be a pullback well below the 200-DMA.
Wait and see....
Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO [View article]
1. pancreatic tumor- Phase 3
2. esophageal tumor- Phase 2
3. Head and neck tumor: Phase 1
Genentech is a MegaCap company and GNVC is a SmallCap company. Hence, the effect on GNVC s.p. is most likely more significant.
DYODD